Rapid Micro Biosystems Research and Development Expenses 2020-2025 | RPID

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Rapid Micro Biosystems research and development expenses from 2020 to 2025. Research and development expenses can be defined as an expense arising from studies and product development processes.

Rapid Micro Biosystems Research and Development Expenses 2020-2025 | RPID

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Rapid Micro Biosystems research and development expenses from 2020 to 2025. Research and development expenses can be defined as an expense arising from studies and product development processes.

Related Stocks
Company Name	Market Cap
Intuitive Surgical (ISRG)	$183.5B
Thermo Fisher Scientific (TMO)	$164.2B
Edwards Lifesciences (EW)	$45.8B
Alcon (ALC)	$43.1B
IDEXX Laboratories (IDXX)	$42.9B
DexCom (DXCM)	$32.7B
IQVIA Holdings (IQV)	$28.2B
Mettler-Toledo (MTD)	$25.4B
STERIS (STE)	$22.4B
Waters (WAT)	$21B
SONOVA HOLDING (SONVY)	$17.4B
Hologic (HOLX)	$14.6B
Sysmex ADR (SSMXY)	$10.6B
Penumbra (PEN)	$9.2B
Masimo (MASI)	$8.8B
Globus Medical (GMED)	$7.7B
Glaukos (GKOS)	$5.9B
Teleflex (TFX)	$5.1B
Integer Holdings (ITGR)	$4.2B
TransMedics (TMDX)	$3.8B
PROCEPT BioRobotics (PRCT)	$3.1B
LivaNova (LIVN)	$2.4B
Veracyte (VCYT)	$2.1B
Nihon Kohden (NHNKY)	$1.9B
Elekta AB (EKTAY)	$1.9B
Alphatec Holdings (ATEC)	$1.6B
Artivion (AORT)	$1.3B
Paragon 28 (FNA)	$1.1B
Pulse Biosciences (PLSE)	$1.1B
OPKO Health (OPK)	$1.1B